Want to join the conversation?
Richmond, Virginia-based $MO said it is reaffirming its guidance for 2016 full year adjusted diluted EPS in a range of $3.00-3.05, representing growth of 7-9% from 2015 base of $2.80. This guidance does not include any impact from the proposed AB InBev and SABMiller business combination, as the deal remains subject to certain approvals.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?